The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
Open accessAbstract
OBJECTIVE We previously reported a high (˜30%) but stable prevalence of diabetic ketoacidosis (DKA) at youth-onset diagnosis of type 1 diabetes (2002 and 2010). Given the changing demographics of youth-onset type 1 diabetes, we sought to evaluate temporal trends in the prevalence of DKA at diagnosis of type 1 diabetes from 2010 to 2016 among youth <20 years of age and evaluate whether any change observed was associated with changes in sociodemographic distribution of those recently diagnosed. RESEARCH DESIGN AND METHODS We calculated prevalence of DKA within 1 month of type 1 diabetes diagnosis by year and evaluated trends over time (2010–2016) (n = 7,612 incident diabetes cases; mean [SD] age 10.1 [4.5] at diagnosis). To assess whether trends observed were attributable to the changing distribution of sociodemographic factors among youth with incident type 1 diabetes, we estimated an adjusted relative risk (RR) of DKA in relation to calendar year, adjusting for age, sex, race/ethnicity, income, education, health insurance status, language, season of diagnosis, and SEARCH for Diabetes in Youth Study site. RESULTS DKA prevalence increased from 35.3% (95% CI 32.2, 38.4) in 2010 to 40.6% (95% CI 37.8, 43.4) in 2016 (Ptrend = 0.01). Adjustment for sociodemographic factors did not substantively change the observed trends. We observed a 2% annual increase in prevalence of DKA at or near diagnosis of type 1 diabetes (crude RR 1.02 [95% CI 1.01, 1.04] and adjusted RR 1.02 [95% CI 1.01, 1.04]; P = 0.01 for both). CONCLUSIONS Prevalence of DKA at or near type 1 diabetes diagnosis has increased from 2010 to 2016, following the high but stable prevalence observed from 2002 to 2010. This increase does not seem to be attributable to the changes in distribution of sociodemographic factors over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Children with type 1 diabetes often present with the hallmark symptoms of polyuria/polydipsia, and approximately half present with diabetic ketoacidosis (DKA) (30 -32).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Children and adolescents often present with DKA as the fi rst manifestation of the disease, and rates in the U.S. have increased dramatically over the past 20 years (30 -32).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“People with type 1 diabetes often present with acute symptoms of diabetes and markedly elevated blood glucose levels, and 25 -50% are diagnosed with life-threatening DKA (30 -32).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taylor, C. A., Bell, J. M., Breiding, M. J., & Xu, L. (2017) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6609a1 · Cited by 2,331
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476
The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions
Hamman, R. F., Bell, R. A., Dabelea, D., D’Agostino, R. B., Dolan, L. M., Imperatore, G., Lawrence, J. M., Linder, B. L., Marcovina, S. M., Mayer‐Davis, E. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0574 · Cited by 637
Sommers, B. D., Blendon, R. J., Orav, E. J., & Epstein, A. M. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.4419 · Cited by 528
Predictors of Acute Complications in Children With Type 1 Diabetes
Rewers, A. (2002) · JAMA · doi:10.1001/jama.287.19.2511 · Cited by 493
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Dabelea, D., Rewers, A., Stafford, J. M., Standiford, D. A., Lawrence, J. M., Saydah, S., Imperatore, G., D’Agostino, R. B., Mayer-Davis, E. J., & Pihoker, C. (2014) · Pediatrics · doi:10.1542/peds.2013-2795 · Cited by 417
Diabetic ketoacidosis and hyperglycemic hyperosmolar state
Wolfsdorf, J. I., Allgrove, J., Craig, M. E., Edge, J., Glaser, N. S., Jain, V., Lee, W. W., Mungai, L., Rosenbloom, A. L., Sperling, M. A., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12165 · Cited by 369
Benoit, S. R., Zhang, Y., Geiss, L. S., Gregg, E. W., & Albright, A. L. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a3 · Cited by 351
Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany
Ziegler, A.-G., Kick, K., Bonifacio, E., Haupt, F., Hippich, M., Dunstheimer, D., Lang, M., Laub, O., Warncke, K., Lange, K., et al. (2020) · JAMA · doi:10.1001/jama.2019.21565 · Cited by 312
Cited by
Sorted by citations
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,841
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Glaser, N. S., Fritsch, M., Priyambada, L., Rewers, A., Cherubini, V., Estrada, S. C., Wolfsdorf, J. I., & Ethel Codner, D. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13406 · Cited by 399
Besser, R. E. J., Bell, K. J., Couper, J., Ziegler, A., Wherrett, D. K., Knip, M., Speake, C., Casteels, K., Driscoll, K. A., Jacobsen, L. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13410 · Cited by 161
Calimag, A. P. P., Chlebek, S., Lerma, E. V., & Chaiban, J. T. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101418 · Cited by 103
The Changing Epidemiology of Type 1 Diabetes: A Global Perspective
Bell, K. J., & Lain, S. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16501 · Cited by 61
Liu, C., Yuan, Y.-C., Guo, M.-N., Xin, Z., Chen, G.-J., Bentley, A. R., Hua, L., Zheng, J.-P., Ekoru, K., & Yang, J.-K. (2021) · Diabetes Care · doi:10.2337/dc21-0342 · Cited by 55
Prevalence, Cost, and Burden of Diabetic Ketoacidosis
Virdi, N. S., Poon, Y., Abaniel, R. M., & Bergenstal, R. M. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0149 · Cited by 57
Screening and Prevention of Type 1 Diabetes: Where Are We?
Simmons, K. M., & Sims, E. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad328 · Cited by 41
Wolf, R. M., Noor, N., Izquierdo, R. E., Jett, D., Rewers, A. H., Majidi, S., SHEANON, N. M., Breidbart, E., Demeterco‐Berggren, C., Lee, J. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13328 · Cited by 34
Bergmann, K. R., Nickel, A. J., Hall, M., Cutler, G. J., Abuzzahab, M. J., Bretscher, B. M., Lammers, S. M., Watson, D., & Hester, G. Z. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.10456 · Cited by 35
The pathophysiology, presentation and classification of Type 1 diabetes
Aamodt, K. I., & Powers, A. C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16628 · Cited by 52
Auzanneau, M., Rosenbauer, J., Warncke, K., Maier, W., Kamrath, C., Hofmann, T. F., Wurm, M., Hammersen, J. E., Schröder, C., Hake, K., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2227 · Cited by 34
Wentworth, J. M., Oakey, H., Craig, M. E., Couper, J., Cameron, F. J., Davis, E. A., Lafferty, A. R. A., Harris, M. A., Wheeler, B. J., Jefferies, C., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13422 · Cited by 31
Leichter, S. B., Felton, J. L., Rasmussen, C. G., Rizzuto, P., Bellini, N. J., Ebekozien, O. A., & Schulman‐Rosenbaum, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf194 · Cited by 32
Charles, M. A., & Leslie, R. D. (2021) · Diabetes · doi:10.2337/dbi21-0012 · Cited by 27
Shahabudin, S., Azmi, N. S., Lani, M. N., Mukhtar, M., & Hossain, M. S. (2024) · Mycoses · doi:10.1111/myc.13753 · Cited by 39
Passanisi, S., Salzano, G., Basile, P., Bombaci, B., Caime, F., Rulli, I., Valenzise, M., Gitto, E., & Lombardo, F. (2023) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-023-01448-1 · Cited by 26
Dhatariya, K., Bergenstal, R. M., Al‐Sofiani, M. E., Albanese-O’Neill, A., Battelino, T., Close, K. L., Block, C. E. M. D., Dutta, S., Galindo, R. J., GhavamiNejad, A., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00331-6 · Cited by 24
Gorchane, A., Ach, T., Sahli, J., Abdelkrim, A. B., Mallouli, M., Bellazreg, F., Hachfi, W., Chaieb, M. C., & Koussay, A. C. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1234256 · Cited by 23
Disparities in access to and use of diabetes technologies and therapeutics: a narrative review
Addala, A., Amedari, M. I., Figg, L. E., & Ebekozien, O. A. (2025) · Diabetologia · doi:10.1007/s00125-025-06494-4 · Cited by 24
Diaz-Thomas, A., Golden, S. H., Dabelea, D., Grimberg, A., Magge, S. N., Safer, J. D., Shumer, D. E., & Stanford, F. C. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad124 · Cited by 25
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab
Mathieu, C., Sims, E. K., Chatenoud, L., James, E. A., Atkinson, M. A., & Herold, K. C. (2025) · Diabetes Care · doi:10.2337/dci25-0066 · Cited by 23
Pietrzak, I., Michalak, A., Seget, S., Bednarska, M., Beń‐Skowronek, I., Bossowski, A. T., Chobot, A. P., Dżygało, K., Głowińska‐Olszewska, B., Górnicka, M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13379 · Cited by 24
Sooy, M., Pyle, L. L., Alonso, G. T., BRONCUCIA, H. C., Rewers, A., Gottlieb, P. A., Simmons, K. M., Rewers, M., & Steck, A. K. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae158 · Cited by 22
Clapin, H. F., Smith, G. J., Vijayanand, S., Jones, T. W., Davis, E. A., & Haynes, A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13327 · Cited by 19
Nagl, K., Waldhoer, T., Hofer, S. E., Fritsch, M., Meraner, D., Prchla, C., Rami-Merhar, B. M., & Fröhlich-Reiterer, E. E. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.820156 · Cited by 18
Hilliard, M. E., Tully, C., Monaghan, M. C., Hildebrandt, T., Wang, C. H., Barber, J. R., Clary, L., Gallagher, K., Levy, W. L., Cogen, F. R., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2704 · Cited by 21
Kahsay, H., & Fenta, T. G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317653 · Cited by 20
Calhoun, P. M., Spanbauer, C., Steck, A. K., Frohnert, B. I., Herman, M. A., Keymeulen, B., Veijola, R., Toppari, J., Desouter, A. K., Gorus, F., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06362-1 · Cited by 12
Adolescents’ experiences living with type 1 diabetes mellitus: A scoping review
Eines, T. F., Kieczka, E. A., Klungnes, S. H., Johnsen, T. A., & Grønvik, C. K. U. (2022) · Nordic journal of nursing research · doi:10.1177/20571585221132652 · Cited by 17
National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
Murphy, M. (2021) · The Journal of Family Practice · doi:10.12788/jfp.0219 · Cited by 14
Bali, I., Al‐Jelaify, M., AlRuthia, Y. S., Mulla, J. Z., Amlih, D. F., Omair, A. I. B., & Khalifah, R. A. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.30043 · Cited by 11
Effective assay technologies fit for large-scale population screening of type 1 diabetes
Jia, X., & Yu, L. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.1034698 · Cited by 10
Hang, T., Huang, J., He, G., Li, J., & Tao, T. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2274-0389 · Cited by 9
Izquierdo, V., Afonso-Bouza, N., Montoto-Méndez, E. M., Silva, G. G., Pazos-Couselo, M., & Rodríguez‐Núñez, A. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06368-2 · Cited by 9
Global Burden of Diabetic Ketoacidosis
Mohan, V., & Lee, K. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251390828 · Cited by 12
The Computational Acid–Base Chemistry of Hepatic Ketoacidosis
Torrens, S., Robergs, R. A., Curry, S. C., & Nalos, M. (2023) · Metabolites · doi:10.3390/metabo13070803 · Cited by 9
Memarian, S., Zolfaghari, A., Gharib, B., & Rajabi, M. M. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07237-9 · Cited by 8
Treatment of Diabetes Mellitus in Children and Adolescents
Yau, M., & Sperling, M. A. (2021) · Cited by 8
Trends in diabetic ketoacidosis in Victoria, Australia 2002–2016
Jones, H. C., Kiburg, K., Lee, M. H., O'Neal, D. N., & MacIsaac, R. J. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01650-0 · Cited by 7
Alsabri, M., Rath, S., Okaruefe, C. O., Yoo, P., Aziz, M. M., Shehada, W., Abdelrahman, S. T., & Carr, L. A. (2025) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-025-00311-3 · Cited by 7
Primary Prevention of CVD with Aspirin: Benefits vs Risks
Weisman (2021) · The Journal of Family Practice · doi:10.12788/jfp.0222 · Cited by 7
Owusu, B. A., Ofori‐Boateng, P., Bankah, E., Barnes, N. A., Atiase, Y., Yorke, E., Dzradosi, M. K., & Doku, D. T. (2024) · SSM - Mental Health · doi:10.1016/j.ssmmh.2024.100368 · Cited by 6
Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?
Ohman-Hanson, R. A., Alonso, G. T., Pyle, L. L., McDonough, R., & Clements, M. A. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13597 · Cited by 6
Aung, N. L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0084 · Cited by 6
Kordonouri, O., Niemeyer, M., Marquardt, E., Berge, T. V. D., Freiberg, C., Menzel, U., Oeverink, R., Galuschka, L., Aschemeier, B., & Lange, K. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06737-2 · Cited by 6
Al‐Abdulrazzaq, D., Othman, F., Qabazard, S., Al-Tararwa, A., Ahmad, D., Al-Sanae, H., & Alkandari, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.908458 · Cited by 5
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children
Dallatana, A., Cremonesi, L., Trombetta, M., Fracasso, G., Nocini, R., Giacomello, L., & Innamorati, G. (2023) · Biomedicines · doi:10.3390/biomedicines11061576 · Cited by 7
Wersäll, J. H., Adolfsson, P., Ekelund, J., Forsander, G., Åkesson, K., & Hanås, R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112282 · Cited by 4
The Future of Dual Glucose–Ketone Monitoring in Youth with Diabetes
Sherr, J. L., & Cobry, E. C. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251370944 · Cited by 4
Hu, Y.-J., Qiu, S.-X., Zhang, J.-N., Lai, Q.-Q., Lin, Y.-L., Liu, L.-Q., Wu, D., Liu, H., Meng, H., Xu, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-84054-3 · Cited by 4
Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
Kushner (2021) · The Journal of Family Practice · doi:10.12788/jfp.0221 · Cited by 6
Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
Петерс (2021) · The Journal of Family Practice · doi:10.12788/jfp.0223 · Cited by 7
Incidencia de diabetes tipo 1 en Navarra, 2009-2020. Evidencia de una estabilización
Iriarte, M. J. G., Larumbe, A. B., Guillén‐Grima, F., Terreros, A. S. D. L., Guendulain, M. J. C., & Llenas, L. F. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.10.005 · Cited by 3
El-Hawary, A. K., Sobh, A., Elsharkawy, A., Gamal, G., & Awad, M. H. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448086.043 · Cited by 3
Ursu, M., Stuparu-Crețu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024) · Children · doi:10.3390/children11101162 · Cited by 3
CONCERNING THE PATHOPHYSIOLOGY OF DIABETIC KETOACIDOSIS: CLASSICAL MECHANISMS AND NEW HYPOTHESES
Bykov, Y. V. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.33009 · Cited by 3
Alfayez, O. M., al-Mutairi, G., Alqudhibi, S. B., Alnefaie, M. A., Alshehri, S. D., Alzaidi, R. K., Alassiri, D. M., Alkhathran, L., Alabdulkarim, D. A., Yami, M. S. A., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238505 · Cited by 2
Niechciał, E., Wais, P., & Kędzia, A. W. (2026) · Scientific Reports · doi:10.1038/s41598-026-38533-4 · Cited by 4
Pérez-Pérez, A., Garcia, R. R., Fresneda, O. S., Alonso, A. A., Dehli, A. C. R., & Galán, I. R. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501771 · Cited by 2
Chobot, A. P., Bossowski, A. T., Jarosz-Chobot, P. A., Myśliwiec, M., Szadkowska, A., Szypowska, A., & Walczak, M. (2026) · Hormone Research in Paediatrics · doi:10.1159/000551858 · Cited by 2
Ziegler, A., Rewers, M. J., Achenbach, P., Bell, K. J., Bonifacio, E., DiMeglio, L. A., Dutta, S., Larsson, H. E., Frohnert, B. I., Griffin, K., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06841-z · Cited by 4
Incidence of type 1 diabetes in Navarra, 2009–2020. Evidence of a stabilization
Iriarte, M. J. G., Brugos‐Larumbe, A., Guillén‐Grima, F., Terreros, A. S. D. L., Guendulain, M. J. C., & Llenas, L. F. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.02.005 · Cited by 2
Diyabetik Ketoasidozlu Hastanın Watson'ın İnsan Bakım Modeline Göre Hemşirelik Bakımı: Olgu Sunumu
KÜÇÜK, S., & Didişen, N. A. (2023) · Sakarya Üniversitesi Holistik Sağlık Dergisi · doi:10.54803/sauhsd.1179516 · Cited by 2
Bergmann, K. R., Bjornstad, P., Abuzzahab, M. J., Ling, Z., Collins-Dippel, E., Nickel, A. J., Watson, D., & Kharbanda, A. B. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-086261 · Cited by 2
Alsolaimani, N., Kattan, M., Algabbani, Z., Awlia, G., Alhamdani, Y., & Al-Agha, A. E. (2024) · Saudi Medical Journal · doi:10.15537/smj.2024.45.12.20240734 · Cited by 2
Management of Immunotherapy-Induced Type 1 Diabetes
Brady, V. (2024) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2024.07.002 · Cited by 2
Petersen, J. J., Juul, S., Kamp, C. B., Faltermeier, P., Sillassen, C. D. B., Santos, T. J. D., & Jakobsen, J. C. (2025) · Systematic Reviews · doi:10.1186/s13643-024-02729-4 · Cited by 1
Emerson, N. D., Ferber, C., JACKSON, N. J., Li, J., Tsay, E., Styne, D. M., Gottschalk, M. E., Mittelman, S. D., Moscicki, A., & Moscicki, A.-B. (2025) · JMIR Diabetes · doi:10.2196/70380 · Cited by 2
Balagamage, C., Pieridou, C., Andrews, A., Sundaram, P., Randell, T. L., Campbell, F., Young, J., Willemsen, R. H., Soni, A., McGrath, M., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70102 · Cited by 1
Alshareef, M. A. U., Bokhari, S., Nawaz, A., Arfaj, L., Alsharif, A. H., Alshamrani, H. M. H., Albogami, F. S., Altowairqi, M., Aqabaw, S., Alobisi, A., et al. (2025) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2025.28.08.1200 · Cited by 1
Pratiques explicatives et dynamiques d’apprentissage professionnel en diabétologie
Mamed, M. D. S., & Grossen, M. (2025) · Éducation et socialisation · doi:10.4000/14rnu · Cited by 1
Wright, R., Cheves, E., Wiggins, S. T., Moultrie, R., Forsythe, A., Andrews, S. M., Frawley, H. E., Cope, H., & Peay, H. L. (2026) · Journal of Community Genetics · doi:10.1007/s12687-026-00863-1 · Cited by 1
Alsabri, M., Aboali, A. A., Rath, S., Hasan, M. T., Haddad, J. A., Aziz, M. M., Lusinski, E., & Qattea, I. (2026) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-026-00340-6 · Cited by 1
Zhang, T., Zhang, H., Huang, S., Nong, T., Mo, X., Huang, J., Zheng, H., & Liu, Y. (2026) · Preventive Medicine · doi:10.1016/j.ypmed.2026.108625 · Cited by 1
New Perspectives in COPD Management
Yawn (2021) · The Journal of Family Practice · doi:10.12788/jfp.0220 · Cited by 1
Saleh, M. A., Ahmed, S. S., & Bakr, Z. H. (2024) · Egyptian Journal of Health Care · doi:10.21608/ejhc.2024.344814 · Cited by 1
Decision Points in the Management of Patients with Diabetic Kidney Disease
Weir (2021) · The Journal of Family Practice · doi:10.12788/jfp.0217 · Cited by 1
Utilizing CGM Ambulatory Glucose Profiles to Optimize Diabetes Management
Miller (2021) · The Journal of Family Practice · doi:10.12788/jfp.0226 · Cited by 1
Cardiometabolic Risk Reduction: A Review of Clinical Guidelines and the Role of SGLT-2 Inhibitors
Reid (2021) · The Journal of Family Practice · doi:10.12788/jfp.0216
Use of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease
Mottl (2021) · The Journal of Family Practice · doi:10.12788/jfp.0225
Improving Shingles Vaccination Rates in Family Medicine
Luther (2021) · The Journal of Family Practice · doi:10.12788/jfp.0218
The Challenge: Finding the Most Appropriate Statin and Dose for Each Patient
Lillo (2021) · The Journal of Family Practice · doi:10.12788/jfp.0224
Alshaikh, A. A., Alsalman, R. Z., Albarqi, N. H., Alqahtani, R. S., Almontashri, A. A., Alshahrani, A., & Alshehri, M. A. (2022) · Pharmacophore · doi:10.51847/e1vwtogf5k
EARLY MARKERS OF DIABETIC NEPHROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS
Ahmadov, G. (2022) · World of Medicine and Biology · doi:10.26724/2079-8334-2022-3-81-13-17
Intraoperative diagnosis of type 1 diabetes and diabetic ketoacidosis during scoliosis surgery
Loh, K. H., Kelley, J. C., & Eagle, S. S. (2023) · Pediatric Anesthesia · doi:10.1111/pan.14686
Early Parameter to Detect the Resolution of Pediatric Diabetic ketoacidosisPreprint
Su, Y.-T., Lo, F., Hsia, S., Lin, J., Chan, O., Yen, C.-W., Chiu, C., Chang, H.-P., & Lee, E. (2023) · Research Square · doi:10.21203/rs.3.rs-3152658/v1
Fang, M., McCoy, R. G., O’Connor, P. J., & Selvin, E. (2023) · American Public Health Association eBooks · doi:10.2105/9780875533377ch12
Alanazi, O. M. L., Alenezi, R. M. L., Alenezi, S. S. S., & Alruwaili, A. B. H. (2023) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2023.v09i12.008
Diabetes tipo 1 e suas principais complicações
Müller, V. M., Costa, J. B. D. O., de Vasconcelos, J. S. C., dos Santos, G. C., & Soares, D. A. (2024) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e14646.2024 · Cited by 2
Aspects of intensive therapy of diabetic ketoacidosis in pediatric practice (literature review)
Bykov, Y. V., & Muravyeva, A. A. (2024) · Messenger of Anesthesiology and Resuscitation · doi:10.24884/2078-5658-2024-21-1-118-124
Tecnología aplicada a la diabetes
Cristoforetti, M. F. (2024) · doi:10.47196/0577
Shebani, M. S., & Khashebi, R. M. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0011
Bolu, S., Aşık, A., & Bucak, İ. H. (2024) · Northwestern Medical Journal · doi:10.54307/2024.nwmj.136
Perioperative Blood Glucose Optimization in Orthopaedic Trauma Patients
Segal, K., Okewunmi, J. O., Mujahid, N., Tong, I. L., Fernandes, A., & Evans, A. R. (2024) · Operative Techniques in Orthopaedics · doi:10.1016/j.oto.2024.101128
Use of Degludec in Youth With Type 1 Diabetes and Recurrent Diabetic Ketoacidosis
Vakharia, M., Huang, X., Minard, C. G., Patel, T., Lyons, S. K., & McKay, S. V. (2024) · Clinical Diabetes · doi:10.2337/cd24-0001
Metadata
- Authors
- Jensen, E. T., Stafford, J. M., Saydah, S., D’Agostino, R. B., Dolan, L. M., Lawrence, J. M., Marcovina, S., Mayer-Davis, E. J., Pihoker, C., Rewers, A., & Dabelea, D.
- Affiliations
- Wake Forest University Health Sciences (US)
- Centers for Disease Control and Prevention (US)
- University of Cincinnati (US)
- Kaiser Permanente (US)
- University of Washington (US)
- Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC
- University of Colorado Denver (US)
- Colorado School of Public Health (US)
- Corresponding author
- Jensen, Elizabeth T.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-07-01
- Volume
- 44
- Issue
- 7
- Pages
- 1573-1578
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8323183
- OpenAlex
- W3170862402
- Cited by
- 137
- References
- 37
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 25 · 2023: 18 · 2022: 18 · 2021: 15
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente (UL1 TR000077, 200-2010-35171, U01 DP000244, U18DP002710-01, U01 DP000248, UL1 TR00423, U18DP002708, 1U18DP002709, U01 DP000246, U48/CCU419249, UL1 TR000062, U18DP006134, DP000254, U18DP006136, U01 DP000247, U48/CCU819241-3, UL1 TR000154, P30 DK57516, U48/CCU919219, U18DP002714, U18DP006139, U18DP006138, 1UC4DK108173, U18DP006133, UL1 TR001425, U58/CCU019235-4, U18DP002710, U18DP000247-06A1, U01 DP000250, U01 DP000254)
- Medical University of South Carolina (TR001450, UL1TR001450, UL1TR000062)
- Wake Forest University (U18DP002714, U18DP002710, U58/CCU019235-4, 200-2010-35171, UL1 TR000077, U18DP006138, U18DP000247-06A1, U18DP006139, U18DP002708, UL1 TR000154, UL1 TR001425, U18DP002710-01, U48/CCU819241-3, U01 DP000247, U18DP006133, UL1 TR00423, 1U18DP002709, P30 DK57516, U48/CCU419249, UL1 TR000062, U18DP006131, U01 DP000246, U18DP006136, DP000254, U48/CCU919219, 1UC4DK108173, U01 DP000244, U01 DP000248, U18DP006134, U01 DP000250, U01 DP000254)
- University of Washington (UL1 TR00423)
- University of Cincinnati (UL1 TR000077, UL1 TR001425)
- University of South Carolina (UL1 TR000062)
- Seattle Children's Research Institute
- Ohio Department of Health (U48/CCU919219, UL1 TR001425, U18DP006136, U01 DP000246, U58/CCU019235-4, U48/CCU419249, U18DP006134, U18DP000247-06A1, UL1 TR000062, U18DP002708, U18DP002710-01, 200-2010-35171, U18DP006139, UL1 TR000154, 1U18DP002709, UL1 TR000077, 1UC4DK108173, UL1 TR00423, P30 DK57516, U01 DP000254, U01 DP000248, U18DP006138, U01 DP000250, U01 DP000247, U18DP006133, U18DP002714, U01 DP000244)
- National Institutes of Health (UL1TR000154, U18DP002708, U18DP006138, U48/CCU419249, UL1TR000423, U18DP006136, UL1TR000062, U58/CCU019235-4, U48/CCU919219, U18DP006139, U18DP006133, U01 DP000250, UL1TR001425, U01 DP000247, U18DP002710, U18DP002714, U01 DP000246, U01 DP000244, 1U18DP002709, U48/CCU819241-3, U18DP000247-06A1, 200-2010-35171, DP000254, U18DP002710-01, U01 DP000254, U01 DP000248, UL1TR001450, U18DP006134, UL1TR000077, TR000077, TR000062, DK57516, TR001425, TR000154)
- Centers for Disease Control and Prevention (UL1 TR00423, U18DP002714, 200-2010-35 171, U01DP000244, U01DP000250, U18DP000247‐06A1, U18DP006138, U18DP006134, U18DP002710, U48/CCU419249, U18DP006136, U58/CCU019235-4, UL1 TR000062, UL1 TR001425, U18DP006139, U18DP002708, U01DP000247, U01DP000248, U18DP002710‐01, DP000254, P30 DK57516, U01DP000254, U01DP000246, UL1 TR000154, U48/CCU919219, U18DP006133, UL1 TR000077, U48/CCU819241‐3, 1UC4DK108173, 1U18DP002709)
- University of North Carolina at Chapel Hill (U01 DP000248, U18DP002714, UL1 TR001425, DP000254, U01 DP000250, U18DP000247-06A1, UL1 TR000077, U48/CCU419249, 200-2010-35171, U01 DP000247, U18DP002710, U18DP006133, U18DP006136, U18DP006134, U48/CCU919219, UL1 TR000062, U48/CCU819241‐3, U58/CCU019235-4, 1U18DP002709, U01 DP000254, U01 DP000246, U01 DP000244, 1UC4DK108173, P30 DK57516, U18DP006139, U18DP002708, UL1 TR00423, U18DP006138, UL1 TR000154, U18DP002710-01)
- University of Colorado Denver (U18DP002714, U01 DP000244, 200-2010-35171, U48/CCU819241-3, U18DP006134, U01 DP000254, U18DP006136, U18DP006133, DP000254, UL1 TR000077, 1U18DP002709, U18DP000247-06A1, U01 DP000246, U01 DP000248, U18DP002708, 1UC4DK108173, U18DP006139, U01 DP000250, UL1 TR000154, U48/CCU419249, U18DP006138, P30 DK57516, U01 DP000247, UL1 TR00423, U18DP002710, UL1 TR000062, U48/CCU919219, U18DP002710-01, U58/CCU019235-4, UL1 TR001425)
- National Institute of Diabetes and Digestive and Kidney Diseases (U18DP006133, 200-2010-35171, U01 DP000250, U18-DP-002714, U01-DP-000247, P30DK057516, 1U18-DP-002709, U01 DP000248, U01 DP000254, U48/CCU919219, U18DP006139, U18DP006131, U48/CCU419249, U01 DP000254, and U18DP002708, UC4DK108173, U18-DP-002708, U48/CCU919219, U01 DP000250, and 200-2010-35171, U01 DP000244, U58/CCU019235-4, U18-DP-000247-06A1, R01DK127208, U48/CCU819241-3, U18DP002710-01, U18DP006136, U18DP006138, U18DP006134, U58/CCU019235-4, U01 DP000244, and U18DP002710-01, U48/CCU819241-3, U01 DP000247, and U18DP000247-06A1, U01-DP-000246, U18DP002710, DP000254, U48/CCU419249)
- National Center for Chronic Disease Prevention and Health Promotion (U01 DP-000247, U18 DP-002709, U18 DP006134, U18-DP-002708, U01-DP000246, U01-DP-000250, U01-DP-000254, U18 DP002714, U18 DP006139, U01 DP000248, U18 DP006138, U18 DP006136, U18 DP006131, U18 DP006133, U01DP000244, U18 DP002710)
- National Center for Advancing Translational Sciences (TR001450, U18DP000247-06A1, U01 DP000244, U58/CCU019235-4, U01 DP000248, U18DP002708, U18DP002714, U48/CCU919219, U01 DP000246, 200-2010-35171, U01 DP000254, U48/CCU419249, U01 DP000250, U18DP006134, U18DP006136, U18DP002710-01, 1U18DP002709, U18DP006138, UL1 TR000062 and UL1 TR001450, U01 DP000247, U18DP006139, U18DP006133)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetic ketoacidosis, type 1 diabetes, youth-onset diabetes, prevalence trends, SEARCH for Diabetes in Youth, sociodemographic factors, diabetes diagnosis, temporal trends
- MeSH terms
- Adolescent, Child, Diabetes Mellitus, Type 1, Ethnicity, Humans, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review